ArticleFrontiers in pharmacology2025

Targeting lipogenesis promotes the synergistic effect of the selective HDAC6 inhibitor ITF3756 with bortezomib in colon cancer cells.

Marzia Franzò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.